The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Abstract
Background— The clinical efficacy of alcohol septal ablation for drug-refractory hypertrophic cardiomyopathy remains unclear. This study examines the outcome of alcohol septal ablation performed at a tertiary hypertrophic cardiomyopathy referral center. Methods and Results— Among 601 patients with severely symptomatic obstructive hypertrophic cardiomyopathy referred for alcohol septal ablation or myectomy from 1998 to 2006, 138 patients (median age, 64 years; 39% men) chose to undergo ablation. Procedural complications included death in 1.4%, sustained ventricular arrhythmias in 3%, tamponade in 3%, and pacemaker implantation in 20%. This rate was higher than a combined complication rate of 5% in age- and gender-matched patients who had undergone septal myectomy at Mayo Clinic ( P <0.0001). Four-year survival free of all mortality was 88.0% (95% confidence interval, 79.4 to 97.5%), which was similar to that of the age- and gender-matched patients who had undergone myectomy ( P =0.18). Six patients had documented ventricular arrhythmias after ablation, 4 of whom had successful intervention. Four-year survival free of death and severe New York Heart Association class III/IV symptoms after septal ablation was 76.4%, and 71 patients (51%) became asymptomatic. Myectomy patients ≤65 years of age had significantly better survival free of death and severe symptoms ( P =0.01). Conclusions— Alcohol septal ablation is an efficacious procedure if performed in an experienced institution and may resolve symptoms in a subset of patients with obstructive hypertrophic cardiomyopathy. However, the procedural complication rate exceeds that of myectomy. Patients ≤65 years of age have better symptom resolution with myectomy. No impairment in short-term survival was noted in this nonrandomized study, but the long-term outcome remains unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · cited 1×
“Eligibility criteria for septal ablation were (1) severe cardiovascular symptoms, defined New York Heart Association (NYHA) class III/IV dyspnea and/or Canadian Cardiovascular Society class III/IV, that were refractory to medical therapy; (2) dynamic LVOT obstruction caused by systolic anterior motion of the mitral va…”
MethodWHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,794
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Kornitzer, M., Berghmans, L., Wilmet, M. D., Darquennes, H., Lagasse, R., & Payen, R. (1988) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 1,270
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 823
Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812
Self-citationNon-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
Sigwart, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91267-3 · Cited by 800
Hypertrophie cardiomyopathy: A discussion of nomenclature
Maron, B. J., & Epstein, S. E. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90160-7 · Cited by 444
Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S., Ralph-Edwards, A., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 333
Knight, C., Kurbaan, A. S., Seggewiss, H., Henein, M., Gunning, M., Harrington, D., Fassbender, D., Gleichmann, U., & Sigwart, U. (1997) · Circulation · doi:10.1161/01.cir.95.8.2075 · Cited by 300
Nagueh, S. F., Ommen, S. R., Lakkis, N. M., Killip, D., Zoghbi, W. A., Schaff, H. V., Danielson, G. K., Quiñones, M. A., Tajik, A. J., & Spencer, W. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01614-x · Cited by 240
Self-citationExtent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy
McCully, R. B., Nishimura, R. A., Tajik, A. J., Schaff, H. V., & Danielson, G. K. (1996) · Circulation · doi:10.1161/01.cir.94.3.467 · Cited by 229
Self-citationMinakata, K., Dearani, J. A., Nishimura, R. A., Maron, B. J., & Danielson, G. K. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.040 · Cited by 228
Self-citationYu, E. H. C., Omran, A. S., Wigle, E. D., Williams, W. G., Siu, S. C., & Rakowski, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01019-6 · Cited by 224
Robbins, R. C., & Stinson, E. B. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70310-0 · Cited by 219
Xin, J., Shiota, T., Lever, H. M., Kapadia, S. R., Sitges, M., Rubin, D. N., Bauer, F., Greenberg, N. L., Agler, D. A., Drinko, J. K., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01656-4 · Cited by 211
Surgical management of hypertrophic obstructive cardiomyopathy
Heric, B., Lytle, B. W., Miller, D. P., Rosenkranz, E. R., Level, H. M., & Cosgrove, D. M. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(05)80026-1 · Cited by 180
Firoozi, S. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3285 · Cited by 177
Mazur, W., Nagueh, S. F., Lakkis, N. M., Middleton, K. J., Killip, D., Roberts, R., & Spencer, W. H. (2001) · Circulation · doi:10.1161/01.cir.103.11.1492 · Cited by 162
van Dockum, W. G., Beek, A. M., ten Cate, F. J., ten Berg, J. M., Bondarenko, O., Götte, M., Twisk, J. W. R., Hofman, M. B. M., Visser, C. A., & van Rossum, A. C. (2005) · Circulation · doi:10.1161/01.cir.0000165084.28065.01 · Cited by 160
Alcohol septal ablation versus surgical septal myectomy
Talreja, D., Nishimura, R. A., Edwards, W. D., Valeti, U. S., Ommen, S. R., Tajik, A. J., Dearani, J. A., Schaff, H. V., & Holmes, D. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.036 · Cited by 154
Self-citationRalph-Edwards, A. C., Woo, A., McCrindle, B. W., Shapero, J. L., Schwartz, L., Rakowski, H., Wigle, E. D., & Williams, W. G. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.08.047 · Cited by 151
FABER, L. (2004) · European Journal of Echocardiography · doi:10.1016/j.euje.2004.01.001 · Cited by 150
Results of surgery for hypertrophic obstructive cardiomyopathy.
Williams, W. G., Wigle, E. D., Rakowski, H., Smallhorn, J. F., LeBlanc, J. G., & Trusler, G. A. (1987) · PubMed · Cited by 124
Gietzen, F. H., Leuner, C., OBERGASSEL, L., Strunk-Mueller, C., & Kuhn, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000022845.80802.9d · Cited by 96
Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique
Holmes, D. R., Valeti, U. S., & Nishimura, R. A. (2005) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20500 · Cited by 95
Self-citationRole of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Kimmelstiel, C. D., & Maron, B. J. (2004) · Circulation · doi:10.1161/01.cir.0000114144.40315.c0 · Cited by 85
Fernandes, V. L. C., Nagueh, S. F., Franklin, J. L., Wang, W., Roberts, R., & Spencer, W. H. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280305 · Cited by 74
Sorajja, P., Nishimura, R. A., Ommen, S. R., Ackerman, M. J., Tajik, A. J., & Gersh, B. J. (2006) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2006.01.005 · Cited by 69
Self-citationNishimura, R. A., & Ommen, S. R. (2006) · Circulation · doi:10.1161/circulationaha.106.660928 · Cited by 66
Self-citationPathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Baggish, A. L., Smith, R. N., Palacios, I. F., Vlahakes, G. J., Yoerger, D. M., Picard, M. H., Lowry, P. A., Jang, I.-K., & Fifer, M. A. (2006) · Heart · doi:10.1136/hrt.2006.092007 · Cited by 65
Surgery for Hypertrophic Obstructive Cardiomyopathy
Maron, B. J. (2005) · Circulation · doi:10.1161/01.cir.0000164396.80300.1a · Cited by 41
Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy
ElBardissi, A. W., Dearani, J. A., Nishimura, R. A., Ommen, S. R., Stulak, J. M., & Schaff, H. V. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61096-3 · Cited by 34
Self-citation
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationHypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citation
Metadata
- Authors
- Sorajja, P., Valeti, U., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R.
- Venue
- Circulation
- Published
- 2008-07-08
- Volume
- 118
- Issue
- 2
- Pages
- 131-139
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2041060696
- Cited by
- 310
- References
- 35
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.